ASCO and the Institute of Medicine’s National Cancer Policy Forum will co-host a workshop on Implementing a National Cancer Clinical Trials System for the 21st Century, Feb. 11-12, 2013.

The workshop will examine activities to implement the recommendations put forth in the 2010 IOM report, “A National Cancer Clinical Trials System for the 21st Century.” The goals of the workshop include summarizing current progress, identifying remaining gaps, and exploring opportunities for closing those gaps within a national clinical trial system.

Registration for the workshop is now open. The agenda is available here.

Two members of ASCO’s Board of Directors and three former ASCO presidents will take part in the workshop:

• ASCO Board members Stephen Grubbs, MD, Helen F. Graham Cancer Center and Christiana Care CCOP, and Robin Zon, MD, Michiana Hematology Oncology, PC and Northern Indiana, will speak about community-based research.

• Former ASCO president George Sledge, MD, Stanford University School of Medicine, will discuss clinical trial prioritization.

• ASCO Chief Medical Officer and former ASCO president Richard L. Schilsky, MD, will moderate a panel discussion on regulatory issues.

• Former ASCO president Sandra Horning, MD, of Genentech, will provide industry perspective.

ASCO member and past Board of Director’s member Monica Bertagnolli, MD, serves as chair of the workshop planning committee. Dr. Bertagnolli is chief, Division of Surgical Oncology, Brigham and Women’s Hospital and group chair, Alliance for Clinical Trials in Oncology.